1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C

Technology appraisal guidance [TA106] Published date: 23 August 2006 Last updated: 01 November 2013

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 Clinical need and practice
  • 3 The technology
  • 4 Evidence and interpretation
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related guidance
  • 8 Review of guidance
  • Appendix A. Appraisal Committee members and NICE project team
  • Appendix B. Sources of evidence considered by the Committee
  • Appendix C. Detail on criteria for audit of the use of peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download
    • Save
    • Save as PDF
    • Save as ePub
    • Save as eBook

Guidance

  • Next

Changes after publication

Changes after publication

March 2012: minor maintenance.

November 2013: partial update.


  • Next